Article
Inactivation of human immunodeficiency virus type 1 reverse transcriptase by oltipraz: evidence for the formation of a stable adduct.
Archives of biochemistry and biophysics - 1 Dec 1995
Chavan S J, Bornmann W G, Flexner C, Prochaska H J
Abstract excerpt
Oltipraz (5-pyrazinyl-4-methyl-1,2-dithiole-3-thione), which is undergoing clinical evaluation as an anticarcinogen, also inhibits HIV-1 replication (IC50 approximately equal to 10 microM). The inactivation of RT appears to be a relevant antiviral mechanism since oltipraz blocks viral replication in acutely infected T-cell lines, but is ineffective in chronically infected ACH-2 cells (H. J. Prochaska, W. G....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
